Clinical Laserthermia Systems AB publishes Year-end report January – December 2023
Summary of the interim report (relates to the Group) Full year (01/01/2023–12/31/2023) · Net sales totaled SEK 8,273,000 (SEK 6,268,000). · Operating profit/loss totaled SEK –65,933,000 (SEK -67,442,000) · Profit/loss after financial items totaled SEK –80,875,000 (SEK -71,265,000). · Basic and diluted earnings per share totaled SEK -0.12 (SEK -0.85). · The equity ratio at December 31, 2023, was 75,4% (18,6%). The fourth quarter (10/01/2023 – 12/31/2023) · Net sales totaled SEK 4,456,000 (SEK 4,295,000). · Operating profit/loss totaled SEK –20,408,000 (SEK -18,